Advertisement

Index by author

March 01, 1995; Volume 272,Issue 3

A

  1. Adachi, M

    1. Effects of cyclopiazonic acid on rat myocardium: inhibition of calcium uptake into sarcoplasmic reticulum.
      S Takahashi, Y Kato, M Adachi, N Agata, H Tanaka and K Shigenobu
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1095-1100;

  2. Agata, N

    1. Effects of cyclopiazonic acid on rat myocardium: inhibition of calcium uptake into sarcoplasmic reticulum.
      S Takahashi, Y Kato, M Adachi, N Agata, H Tanaka and K Shigenobu
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1095-1100;

  3. Ansanay, H

    1. Homologous desensitization of 5-hydroxytryptamine4 receptors in rat esophagus: functional and second messenger studies.
      P Rondé, H Ansanay, A Dumuis, R Miller and J Bockaert
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 977-983;

  4. Arvola, P

    1. Arterial function after trichlormethiazide therapy in spontaneously hypertensive rats.
      M Kähönen, H Mäkynen, P Arvola, H Wuorela and I Pörsti
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1223-1230;

  5. Astolfi, M

    1. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
      R Patacchini, L Quartara, M Astolfi, C Goso, A Giachetti and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1082-1087;

  6. Atchison, W D

    1. Methylmercury mobilizes Ca++ from intracellular stores sensitive to inositol 1,4,5-trisphosphate in NG108-15 cells.
      M F Hare and W D Atchison
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1016-1023;

  7. Azer, S A

    1. Mechanism of ketoconazole-induced elevation of individual serum bile acids in the rat: relationship to the effect of ketoconazole on bile acid uptake by isolated hepatocytes.
      S A Azer, V Kukongviriyapan and N H Stacey
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1231-1237;

B

  1. Ballatori, N

    1. Methylmercury-thiol uptake into cultured brain capillary endothelial cells on amino acid system L.
      E M Mokrzan, L E Kerper, N Ballatori and T W Clarkson
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1277-1284;

  2. Bannenberg, G

    1. Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung.
      G Bannenberg, J Xue, L Engman, I Cotgreave, P Moldéus and A Ryrfeldt
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1238-1245;

  3. Bayer, B M

    1. Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking.
      L R Flores, S M Wahl and B M Bayer
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1246-1251;

  4. Beck, G

    1. Nonpeptide endothelin receptor antagonists: IV. Identification of receptors in rabbit colonic mucosa and smooth muscle and correlation with physiological effects.
      P L Smith, C P Lee, M Pullen, E H Ohlstein, G Beck, E P Eddy and P Nambi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1204-1210;

  5. Belardinelli, L

    1. Homologous desensitization of the A1-adenosine receptor system in the guinea pig atrioventricular node.
      D M Dennis, J C Shryock and L Belardinelli
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1024-1035;

  6. Bennett, B A

    1. Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.
      B A Bennett, C H Wichems, C K Hollingsworth, H M Davies, C Thornley, T Sexton and S R Childers
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1176-1186;

  7. Bidlack, J M

    1. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure.
      D B Joseph and J M Bidlack
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 970-976;

  8. Bird, J E

    1. BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.
      M L Webb, J E Bird, E C Liu, P M Rose, R Serafino, P D Stein and S Moreland
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1124-1134;

  9. Birkett, D J

    1. Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism.
      J O Miners, D L Rees, L Valente, M E Veronese and D J Birkett
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1076-1081;

  10. Bjur, R A

    1. Differences in purinoceptor modulation of norepinephrine release between caudal arteries of normotensive and hypertensive rats.
      K Shinozuka, M Kunitomo, K Hattori, R A Bjur and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1193-1198;

  11. Bley, K R

    1. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine.
      D W Bonhaus, K R Bley, C A Broka, D J Fontana, E Leung, R Lewis, A Shieh and E H Wong
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1199-1203;

  12. Bockaert, J

    1. Homologous desensitization of 5-hydroxytryptamine4 receptors in rat esophagus: functional and second messenger studies.
      P Rondé, H Ansanay, A Dumuis, R Miller and J Bockaert
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 977-983;

  13. Bonhaus, D W

    1. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine.
      D W Bonhaus, K R Bley, C A Broka, D J Fontana, E Leung, R Lewis, A Shieh and E H Wong
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1199-1203;

  14. Broka, C A

    1. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine.
      D W Bonhaus, K R Bley, C A Broka, D J Fontana, E Leung, R Lewis, A Shieh and E H Wong
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1199-1203;

  15. Brune, M E

    1. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
      A A Hancock, S A Buckner, W J Giardina, M E Brune, J Y Lee, P A Morse, K W Oheim, D S Stanisic, R B Warner and D J Kerkman
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1160-1169;

  16. Bryant, H U

    1. Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.
      M Sato, J Kim, L L Short, C W Slemenda and H U Bryant
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1252-1259;

  17. Buckner, S A

    1. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
      A A Hancock, S A Buckner, W J Giardina, M E Brune, J Y Lee, P A Morse, K W Oheim, D S Stanisic, R B Warner and D J Kerkman
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1160-1169;

C

  1. Cai, J J

    1. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F.
      X Tao, J J Cai and P E Lipsky
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1305-1312;

  2. Carter, G

    1. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors.
      W R Tracey, J Tse and G Carter
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1011-1015;

  3. Chakder, S

    1. Human recombinant hemoglobin (rHb1.1) inhibits nonadrenergic noncholinergic (NANC) nerve-mediated relaxation of internal anal sphincter.
      S Rattan, G J Rosenthal and S Chakder
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1211-1216;

  4. Childers, S R

    1. Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.
      B A Bennett, C H Wichems, C K Hollingsworth, H M Davies, C Thornley, T Sexton and S R Childers
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1176-1186;

  5. Clarkson, T W

    1. Methylmercury-thiol uptake into cultured brain capillary endothelial cells on amino acid system L.
      E M Mokrzan, L E Kerper, N Ballatori and T W Clarkson
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1277-1284;

  6. Conanan, N D

    1. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
      J L Ellis and N D Conanan
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 997-1004;

  7. Cotgreave, I

    1. Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung.
      G Bannenberg, J Xue, L Engman, I Cotgreave, P Moldéus and A Ryrfeldt
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1238-1245;

D

  1. Davies, H M

    1. Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.
      B A Bennett, C H Wichems, C K Hollingsworth, H M Davies, C Thornley, T Sexton and S R Childers
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1176-1186;

  2. Dement, W C

    1. Effect of 5-HT1A receptor agonists and antagonists on canine cataplexy.
      S Nishino, J Shelton, A Renaud, W C Dement and E Mignot
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1170-1175;

  3. Dennis, D M

    1. Homologous desensitization of the A1-adenosine receptor system in the guinea pig atrioventricular node.
      D M Dennis, J C Shryock and L Belardinelli
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1024-1035;

  4. Drieze, J M

    1. The acute effects of cocaine on anterior pituitary hormones in ovariectomized rhesus monkeys.
      N K Mello, Z Sarnyai, J H Mendelson, J M Drieze and M Kelly
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1059-1066;

  5. Dumuis, A

    1. Homologous desensitization of 5-hydroxytryptamine4 receptors in rat esophagus: functional and second messenger studies.
      P Rondé, H Ansanay, A Dumuis, R Miller and J Bockaert
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 977-983;

  6. Dworkin, S I

    1. Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats.
      T J Martin, S I Dworkin and J E Smith
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1135-1140;

E

  1. Ebinger, G

    1. Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study.
      K Van Belle, S Sarre, G Ebinger and Y Michotte
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1217-1222;

  2. Eddy, E P

    1. Nonpeptide endothelin receptor antagonists: IV. Identification of receptors in rabbit colonic mucosa and smooth muscle and correlation with physiological effects.
      P L Smith, C P Lee, M Pullen, E H Ohlstein, G Beck, E P Eddy and P Nambi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1204-1210;

  3. Eigyo, M

    1. Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats.
      A Katoh, M Eigyo, C Ishibashi, Y Naitoh, M Takeuchi, N Ibii, M Ikeda and A Matsushita
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1067-1075;

  4. el-Fawal, H A

    1. Airway smooth muscle relaxant effects of the cocaine pyrolysis product, methylecgonidine.
      H A el-Fawal and R W Wood
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 991-996;

  5. Ellis, J L

    1. Modulation of relaxant responses evoked by a nitric oxide donor and by nonadrenergic, noncholinergic stimulation by isozyme-selective phosphodiesterase inhibitors in guinea pig trachea.
      J L Ellis and N D Conanan
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 997-1004;

  6. Engman, L

    1. Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung.
      G Bannenberg, J Xue, L Engman, I Cotgreave, P Moldéus and A Ryrfeldt
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1238-1245;

F

  1. Fedan, J S

    1. Nitric oxide synthase inhibitor and lipopolysaccharide effects on reactivity of guinea pig airways.
      J S Fedan, T E Warner, L X Yuan, V a Robinson and D G Frazer
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1141-1150;

  2. Flores, L R

    1. Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking.
      L R Flores, S M Wahl and B M Bayer
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1246-1251;

  3. Fontana, D J

    1. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine.
      D W Bonhaus, K R Bley, C A Broka, D J Fontana, E Leung, R Lewis, A Shieh and E H Wong
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1199-1203;

  4. Frazer, D G

    1. Nitric oxide synthase inhibitor and lipopolysaccharide effects on reactivity of guinea pig airways.
      J S Fedan, T E Warner, L X Yuan, V a Robinson and D G Frazer
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1141-1150;

  5. Furdon, P J

    1. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
      M W Verghese, R T McConnell, A B Strickland, R C Gooding, S A Stimpson, D P Yarnall, J D Taylor and P J Furdon
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1313-1320;

  6. Furukawa, S

    1. 4-Methylcatechol, an inducer of nerve growth factor synthesis, enhances peripheral nerve regeneration across nerve gaps.
      K Kaechi, R Ikegami, N Nakamura, M Nakajima, Y Furukawa and S Furukawa
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1300-1304;

  7. Furukawa, Y

    1. 4-Methylcatechol, an inducer of nerve growth factor synthesis, enhances peripheral nerve regeneration across nerve gaps.
      K Kaechi, R Ikegami, N Nakamura, M Nakajima, Y Furukawa and S Furukawa
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1300-1304;

G

  1. Giachetti, A

    1. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
      R Patacchini, L Quartara, M Astolfi, C Goso, A Giachetti and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1082-1087;

  2. Giardina, W J

    1. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
      A A Hancock, S A Buckner, W J Giardina, M E Brune, J Y Lee, P A Morse, K W Oheim, D S Stanisic, R B Warner and D J Kerkman
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1160-1169;

  3. Gooding, R C

    1. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
      M W Verghese, R T McConnell, A B Strickland, R C Gooding, S A Stimpson, D P Yarnall, J D Taylor and P J Furdon
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1313-1320;

  4. Goso, C

    1. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
      R Patacchini, L Quartara, M Astolfi, C Goso, A Giachetti and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1082-1087;

H

  1. Hanai, H

    1. Serotonin uptake and its modulation in rat jejunal enterocyte preparation.
      S Takayanagi, H Hanai, J Kumagai and E Kaneko
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1151-1159;

  2. Hancock, A A

    1. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
      A A Hancock, S A Buckner, W J Giardina, M E Brune, J Y Lee, P A Morse, K W Oheim, D S Stanisic, R B Warner and D J Kerkman
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1160-1169;

  3. Hare, M F

    1. Methylmercury mobilizes Ca++ from intracellular stores sensitive to inositol 1,4,5-trisphosphate in NG108-15 cells.
      M F Hare and W D Atchison
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1016-1023;

  4. Hattori, K

    1. Differences in purinoceptor modulation of norepinephrine release between caudal arteries of normotensive and hypertensive rats.
      K Shinozuka, M Kunitomo, K Hattori, R A Bjur and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1193-1198;

  5. Henry, D P

    1. In vivo renal production and tubular secretion of tyramine.
      J W Van Huysse, D P Henry and L R Willis
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1187-1192;

  6. Hines, R N

    1. Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit.
      S E Shehin-Johnson, D E Williams, S Larsen-Su, D M Stresser and R N Hines
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1293-1299;

  7. Hodges, J C

    1. Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
      J A Keiser, M J Ryan, R L Panek, J C Hodges and I Sircar
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 963-969;

  8. Hollingsworth, C K

    1. Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.
      B A Bennett, C H Wichems, C K Hollingsworth, H M Davies, C Thornley, T Sexton and S R Childers
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1176-1186;

I

  1. Ibii, N

    1. Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats.
      A Katoh, M Eigyo, C Ishibashi, Y Naitoh, M Takeuchi, N Ibii, M Ikeda and A Matsushita
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1067-1075;

  2. Igarashi, K

    1. Antagonist properties of polyamines and bis(ethyl)polyamines at N-methyl-D-aspartate receptors.
      K Igarashi and K Williams
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1101-1109;

  3. Ikeda, M

    1. Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats.
      A Katoh, M Eigyo, C Ishibashi, Y Naitoh, M Takeuchi, N Ibii, M Ikeda and A Matsushita
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1067-1075;

  4. Ikeda, T

    1. Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis.
      M Matsumoto, M Yoshioka, H Togashi, M Tochihara, T Ikeda and H Saito
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1044-1051;

  5. Ikegami, R

    1. 4-Methylcatechol, an inducer of nerve growth factor synthesis, enhances peripheral nerve regeneration across nerve gaps.
      K Kaechi, R Ikegami, N Nakamura, M Nakajima, Y Furukawa and S Furukawa
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1300-1304;

  6. Ishibashi, C

    1. Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats.
      A Katoh, M Eigyo, C Ishibashi, Y Naitoh, M Takeuchi, N Ibii, M Ikeda and A Matsushita
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1067-1075;

J

  1. Joseph, D B

    1. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure.
      D B Joseph and J M Bidlack
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 970-976;

K

  1. Kaechi, K

    1. 4-Methylcatechol, an inducer of nerve growth factor synthesis, enhances peripheral nerve regeneration across nerve gaps.
      K Kaechi, R Ikegami, N Nakamura, M Nakajima, Y Furukawa and S Furukawa
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1300-1304;

  2. Kähönen, M

    1. Arterial function after trichlormethiazide therapy in spontaneously hypertensive rats.
      M Kähönen, H Mäkynen, P Arvola, H Wuorela and I Pörsti
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1223-1230;

  3. Kaneko, E

    1. Serotonin uptake and its modulation in rat jejunal enterocyte preparation.
      S Takayanagi, H Hanai, J Kumagai and E Kaneko
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1151-1159;

  4. Kato, Y

    1. Effects of cyclopiazonic acid on rat myocardium: inhibition of calcium uptake into sarcoplasmic reticulum.
      S Takahashi, Y Kato, M Adachi, N Agata, H Tanaka and K Shigenobu
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1095-1100;

  5. Katoh, A

    1. Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats.
      A Katoh, M Eigyo, C Ishibashi, Y Naitoh, M Takeuchi, N Ibii, M Ikeda and A Matsushita
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1067-1075;

  6. Keiser, J A

    1. Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
      J A Keiser, M J Ryan, R L Panek, J C Hodges and I Sircar
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 963-969;

  7. Kelly, M

    1. The acute effects of cocaine on anterior pituitary hormones in ovariectomized rhesus monkeys.
      N K Mello, Z Sarnyai, J H Mendelson, J M Drieze and M Kelly
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1059-1066;

  8. Kerkman, D J

    1. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
      A A Hancock, S A Buckner, W J Giardina, M E Brune, J Y Lee, P A Morse, K W Oheim, D S Stanisic, R B Warner and D J Kerkman
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1160-1169;

  9. Kerper, L E

    1. Methylmercury-thiol uptake into cultured brain capillary endothelial cells on amino acid system L.
      E M Mokrzan, L E Kerper, N Ballatori and T W Clarkson
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1277-1284;

  10. Keyler, D E

    1. Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.
      D E Keyler, D G Le Couteur, S M Pond, J V St Peter and P R Pentel
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1117-1123;

  11. Khan, I

    1. Messenger RNAs for neurokinin and histamine receptor subtypes in isolated canine colonic crypts.
      I Khan, N Lapierre and P K Rangachari
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1285-1292;

  12. Kim, J

    1. Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.
      M Sato, J Kim, L L Short, C W Slemenda and H U Bryant
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1252-1259;

  13. Kukongviriyapan, V

    1. Mechanism of ketoconazole-induced elevation of individual serum bile acids in the rat: relationship to the effect of ketoconazole on bile acid uptake by isolated hepatocytes.
      S A Azer, V Kukongviriyapan and N H Stacey
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1231-1237;

  14. Kumagai, J

    1. Serotonin uptake and its modulation in rat jejunal enterocyte preparation.
      S Takayanagi, H Hanai, J Kumagai and E Kaneko
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1151-1159;

  15. Kunitomo, M

    1. Differences in purinoceptor modulation of norepinephrine release between caudal arteries of normotensive and hypertensive rats.
      K Shinozuka, M Kunitomo, K Hattori, R A Bjur and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1193-1198;

L

  1. Lapierre, N

    1. Messenger RNAs for neurokinin and histamine receptor subtypes in isolated canine colonic crypts.
      I Khan, N Lapierre and P K Rangachari
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1285-1292;

  2. Larsen-Su, S

    1. Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit.
      S E Shehin-Johnson, D E Williams, S Larsen-Su, D M Stresser and R N Hines
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1293-1299;

  3. Le Couteur, D G

    1. Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.
      D E Keyler, D G Le Couteur, S M Pond, J V St Peter and P R Pentel
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1117-1123;

  4. Lee, C P

    1. Nonpeptide endothelin receptor antagonists: IV. Identification of receptors in rabbit colonic mucosa and smooth muscle and correlation with physiological effects.
      P L Smith, C P Lee, M Pullen, E H Ohlstein, G Beck, E P Eddy and P Nambi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1204-1210;

  5. Lee, J Y

    1. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
      A A Hancock, S A Buckner, W J Giardina, M E Brune, J Y Lee, P A Morse, K W Oheim, D S Stanisic, R B Warner and D J Kerkman
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1160-1169;

  6. Leung, E

    1. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine.
      D W Bonhaus, K R Bley, C A Broka, D J Fontana, E Leung, R Lewis, A Shieh and E H Wong
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1199-1203;

  7. Lewis, R

    1. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine.
      D W Bonhaus, K R Bley, C A Broka, D J Fontana, E Leung, R Lewis, A Shieh and E H Wong
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1199-1203;

  8. Lipsky, P E

    1. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F.
      X Tao, J J Cai and P E Lipsky
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1305-1312;

  9. Liu, E C

    1. BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.
      M L Webb, J E Bird, E C Liu, P M Rose, R Serafino, P D Stein and S Moreland
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1124-1134;

M

  1. Madden, S

    1. Metabolism and bioactivation of clozapine by human liver in vitro.
      M Pirmohamed, D Williams, S Madden, E Templeton and B K Park
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 984-990;

  2. Maggi, C A

    1. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
      R Patacchini, L Quartara, M Astolfi, C Goso, A Giachetti and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1082-1087;

  3. Mäkynen, H

    1. Arterial function after trichlormethiazide therapy in spontaneously hypertensive rats.
      M Kähönen, H Mäkynen, P Arvola, H Wuorela and I Pörsti
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1223-1230;

  4. Martin, T J

    1. Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats.
      T J Martin, S I Dworkin and J E Smith
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1135-1140;

  5. Matsumoto, M

    1. Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis.
      M Matsumoto, M Yoshioka, H Togashi, M Tochihara, T Ikeda and H Saito
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1044-1051;

  6. Matsushita, A

    1. Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats.
      A Katoh, M Eigyo, C Ishibashi, Y Naitoh, M Takeuchi, N Ibii, M Ikeda and A Matsushita
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1067-1075;

  7. McConnell, R T

    1. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
      M W Verghese, R T McConnell, A B Strickland, R C Gooding, S A Stimpson, D P Yarnall, J D Taylor and P J Furdon
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1313-1320;

  8. McKee, M

    1. Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase.
      C Scavone, C Scanlon, M McKee and J A Nathanson
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1036-1043;

  9. Meaney, M J

    1. Increased production of inositol phosphates and diacylglycerol in aged cognitively impaired rats after stimulation of muscarinic, metabotropic-glutamate and endothelin receptors.
      A Parent, W Rowe, M J Meaney and R Quirion
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1110-1116;

  10. Mello, N K

    1. The acute effects of cocaine on anterior pituitary hormones in ovariectomized rhesus monkeys.
      N K Mello, Z Sarnyai, J H Mendelson, J M Drieze and M Kelly
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1059-1066;

  11. Mendelson, J H

    1. The acute effects of cocaine on anterior pituitary hormones in ovariectomized rhesus monkeys.
      N K Mello, Z Sarnyai, J H Mendelson, J M Drieze and M Kelly
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1059-1066;

  12. Michotte, Y

    1. Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study.
      K Van Belle, S Sarre, G Ebinger and Y Michotte
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1217-1222;

  13. Mignot, E

    1. Effect of 5-HT1A receptor agonists and antagonists on canine cataplexy.
      S Nishino, J Shelton, A Renaud, W C Dement and E Mignot
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1170-1175;

  14. Miller, R

    1. Homologous desensitization of 5-hydroxytryptamine4 receptors in rat esophagus: functional and second messenger studies.
      P Rondé, H Ansanay, A Dumuis, R Miller and J Bockaert
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 977-983;

  15. Miners, J O

    1. Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism.
      J O Miners, D L Rees, L Valente, M E Veronese and D J Birkett
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1076-1081;

  16. Minneman, K P

    1. Coexisting beta-1 and beta-2-adrenergic receptors with differential receptor reserves in rat C6 glioma cells.
      H Zhong and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1088-1094;

  17. Mitrovic, I

    1. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
      I Mitrovic and T C Napier
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1260-1270;

  18. Mokrzan, E M

    1. Methylmercury-thiol uptake into cultured brain capillary endothelial cells on amino acid system L.
      E M Mokrzan, L E Kerper, N Ballatori and T W Clarkson
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1277-1284;

  19. Moldéus, P

    1. Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung.
      G Bannenberg, J Xue, L Engman, I Cotgreave, P Moldéus and A Ryrfeldt
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1238-1245;

  20. Moreland, S

    1. BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.
      M L Webb, J E Bird, E C Liu, P M Rose, R Serafino, P D Stein and S Moreland
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1124-1134;

  21. Morse, P A

    1. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
      A A Hancock, S A Buckner, W J Giardina, M E Brune, J Y Lee, P A Morse, K W Oheim, D S Stanisic, R B Warner and D J Kerkman
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1160-1169;

N

  1. Naitoh, Y

    1. Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats.
      A Katoh, M Eigyo, C Ishibashi, Y Naitoh, M Takeuchi, N Ibii, M Ikeda and A Matsushita
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1067-1075;

  2. Nakajima, M

    1. 4-Methylcatechol, an inducer of nerve growth factor synthesis, enhances peripheral nerve regeneration across nerve gaps.
      K Kaechi, R Ikegami, N Nakamura, M Nakajima, Y Furukawa and S Furukawa
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1300-1304;

  3. Nakamura, N

    1. 4-Methylcatechol, an inducer of nerve growth factor synthesis, enhances peripheral nerve regeneration across nerve gaps.
      K Kaechi, R Ikegami, N Nakamura, M Nakajima, Y Furukawa and S Furukawa
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1300-1304;

  4. Nambi, P

    1. Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors.
      D E Semler, E H Ohlstein, P Nambi, C Slater and P H Stern
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1052-1058;
    2. Nonpeptide endothelin receptor antagonists: IV. Identification of receptors in rabbit colonic mucosa and smooth muscle and correlation with physiological effects.
      P L Smith, C P Lee, M Pullen, E H Ohlstein, G Beck, E P Eddy and P Nambi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1204-1210;

  5. Napier, T C

    1. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
      I Mitrovic and T C Napier
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1260-1270;

  6. Nathanson, J A

    1. Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase.
      C Scavone, C Scanlon, M McKee and J A Nathanson
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1036-1043;

  7. Nishino, S

    1. Effect of 5-HT1A receptor agonists and antagonists on canine cataplexy.
      S Nishino, J Shelton, A Renaud, W C Dement and E Mignot
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1170-1175;

O

  1. Oheim, K W

    1. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
      A A Hancock, S A Buckner, W J Giardina, M E Brune, J Y Lee, P A Morse, K W Oheim, D S Stanisic, R B Warner and D J Kerkman
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1160-1169;

  2. Ohlstein, E H

    1. Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors.
      D E Semler, E H Ohlstein, P Nambi, C Slater and P H Stern
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1052-1058;
    2. Nonpeptide endothelin receptor antagonists: IV. Identification of receptors in rabbit colonic mucosa and smooth muscle and correlation with physiological effects.
      P L Smith, C P Lee, M Pullen, E H Ohlstein, G Beck, E P Eddy and P Nambi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1204-1210;

P

  1. Panek, R L

    1. Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
      J A Keiser, M J Ryan, R L Panek, J C Hodges and I Sircar
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 963-969;

  2. Parent, A

    1. Increased production of inositol phosphates and diacylglycerol in aged cognitively impaired rats after stimulation of muscarinic, metabotropic-glutamate and endothelin receptors.
      A Parent, W Rowe, M J Meaney and R Quirion
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1110-1116;

  3. Park, B K

    1. Metabolism and bioactivation of clozapine by human liver in vitro.
      M Pirmohamed, D Williams, S Madden, E Templeton and B K Park
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 984-990;

  4. Patacchini, R

    1. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
      R Patacchini, L Quartara, M Astolfi, C Goso, A Giachetti and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1082-1087;

  5. Pentel, P R

    1. Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.
      D E Keyler, D G Le Couteur, S M Pond, J V St Peter and P R Pentel
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1117-1123;

  6. Pirmohamed, M

    1. Metabolism and bioactivation of clozapine by human liver in vitro.
      M Pirmohamed, D Williams, S Madden, E Templeton and B K Park
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 984-990;

  7. Planas, E

    1. Peripheral effects of naloxone in mice with acute diarrhea associated with intestinal inflammation.
      O Pol, E Planas and M M Puig
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1271-1276;

  8. Pol, O

    1. Peripheral effects of naloxone in mice with acute diarrhea associated with intestinal inflammation.
      O Pol, E Planas and M M Puig
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1271-1276;

  9. Pond, S M

    1. Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.
      D E Keyler, D G Le Couteur, S M Pond, J V St Peter and P R Pentel
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1117-1123;

  10. Pörsti, I

    1. Arterial function after trichlormethiazide therapy in spontaneously hypertensive rats.
      M Kähönen, H Mäkynen, P Arvola, H Wuorela and I Pörsti
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1223-1230;

  11. Puig, M M

    1. Peripheral effects of naloxone in mice with acute diarrhea associated with intestinal inflammation.
      O Pol, E Planas and M M Puig
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1271-1276;

  12. Pullen, M

    1. Nonpeptide endothelin receptor antagonists: IV. Identification of receptors in rabbit colonic mucosa and smooth muscle and correlation with physiological effects.
      P L Smith, C P Lee, M Pullen, E H Ohlstein, G Beck, E P Eddy and P Nambi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1204-1210;

Q

  1. Quartara, L

    1. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
      R Patacchini, L Quartara, M Astolfi, C Goso, A Giachetti and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1082-1087;

  2. Quirion, R

    1. Increased production of inositol phosphates and diacylglycerol in aged cognitively impaired rats after stimulation of muscarinic, metabotropic-glutamate and endothelin receptors.
      A Parent, W Rowe, M J Meaney and R Quirion
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1110-1116;

R

  1. Rangachari, P K

    1. Messenger RNAs for neurokinin and histamine receptor subtypes in isolated canine colonic crypts.
      I Khan, N Lapierre and P K Rangachari
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1285-1292;

  2. Rattan, S

    1. Human recombinant hemoglobin (rHb1.1) inhibits nonadrenergic noncholinergic (NANC) nerve-mediated relaxation of internal anal sphincter.
      S Rattan, G J Rosenthal and S Chakder
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1211-1216;

  3. Rees, D L

    1. Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism.
      J O Miners, D L Rees, L Valente, M E Veronese and D J Birkett
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1076-1081;

  4. Renaud, A

    1. Effect of 5-HT1A receptor agonists and antagonists on canine cataplexy.
      S Nishino, J Shelton, A Renaud, W C Dement and E Mignot
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1170-1175;

  5. Robinson, V a

    1. Nitric oxide synthase inhibitor and lipopolysaccharide effects on reactivity of guinea pig airways.
      J S Fedan, T E Warner, L X Yuan, V a Robinson and D G Frazer
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1141-1150;

  6. Rondé, P

    1. Homologous desensitization of 5-hydroxytryptamine4 receptors in rat esophagus: functional and second messenger studies.
      P Rondé, H Ansanay, A Dumuis, R Miller and J Bockaert
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 977-983;

  7. Rose, P M

    1. BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.
      M L Webb, J E Bird, E C Liu, P M Rose, R Serafino, P D Stein and S Moreland
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1124-1134;

  8. Rosenthal, G J

    1. Human recombinant hemoglobin (rHb1.1) inhibits nonadrenergic noncholinergic (NANC) nerve-mediated relaxation of internal anal sphincter.
      S Rattan, G J Rosenthal and S Chakder
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1211-1216;

  9. Rowe, W

    1. Increased production of inositol phosphates and diacylglycerol in aged cognitively impaired rats after stimulation of muscarinic, metabotropic-glutamate and endothelin receptors.
      A Parent, W Rowe, M J Meaney and R Quirion
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1110-1116;

  10. Ryan, M J

    1. Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
      J A Keiser, M J Ryan, R L Panek, J C Hodges and I Sircar
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 963-969;

  11. Ryrfeldt, A

    1. Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung.
      G Bannenberg, J Xue, L Engman, I Cotgreave, P Moldéus and A Ryrfeldt
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1238-1245;

S

  1. Saito, H

    1. Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis.
      M Matsumoto, M Yoshioka, H Togashi, M Tochihara, T Ikeda and H Saito
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1044-1051;

  2. Sarnyai, Z

    1. The acute effects of cocaine on anterior pituitary hormones in ovariectomized rhesus monkeys.
      N K Mello, Z Sarnyai, J H Mendelson, J M Drieze and M Kelly
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1059-1066;

  3. Sarre, S

    1. Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study.
      K Van Belle, S Sarre, G Ebinger and Y Michotte
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1217-1222;

  4. Sato, M

    1. Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.
      M Sato, J Kim, L L Short, C W Slemenda and H U Bryant
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1252-1259;

  5. Scanlon, C

    1. Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase.
      C Scavone, C Scanlon, M McKee and J A Nathanson
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1036-1043;

  6. Scavone, C

    1. Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase.
      C Scavone, C Scanlon, M McKee and J A Nathanson
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1036-1043;

  7. Semler, D E

    1. Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors.
      D E Semler, E H Ohlstein, P Nambi, C Slater and P H Stern
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1052-1058;

  8. Serafino, R

    1. BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.
      M L Webb, J E Bird, E C Liu, P M Rose, R Serafino, P D Stein and S Moreland
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1124-1134;

  9. Sexton, T

    1. Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.
      B A Bennett, C H Wichems, C K Hollingsworth, H M Davies, C Thornley, T Sexton and S R Childers
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1176-1186;

  10. Shehin-Johnson, S E

    1. Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit.
      S E Shehin-Johnson, D E Williams, S Larsen-Su, D M Stresser and R N Hines
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1293-1299;

  11. Sheldon, R S

    1. Ring and link requirements for tocainide binding to the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R S Sheldon and E Thakore
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1005-1010;

  12. Shelton, J

    1. Effect of 5-HT1A receptor agonists and antagonists on canine cataplexy.
      S Nishino, J Shelton, A Renaud, W C Dement and E Mignot
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1170-1175;

  13. Shieh, A

    1. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine.
      D W Bonhaus, K R Bley, C A Broka, D J Fontana, E Leung, R Lewis, A Shieh and E H Wong
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1199-1203;

  14. Shigenobu, K

    1. Effects of cyclopiazonic acid on rat myocardium: inhibition of calcium uptake into sarcoplasmic reticulum.
      S Takahashi, Y Kato, M Adachi, N Agata, H Tanaka and K Shigenobu
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1095-1100;

  15. Shinozuka, K

    1. Differences in purinoceptor modulation of norepinephrine release between caudal arteries of normotensive and hypertensive rats.
      K Shinozuka, M Kunitomo, K Hattori, R A Bjur and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1193-1198;

  16. Short, L L

    1. Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.
      M Sato, J Kim, L L Short, C W Slemenda and H U Bryant
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1252-1259;

  17. Shryock, J C

    1. Homologous desensitization of the A1-adenosine receptor system in the guinea pig atrioventricular node.
      D M Dennis, J C Shryock and L Belardinelli
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1024-1035;

  18. Sircar, I

    1. Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
      J A Keiser, M J Ryan, R L Panek, J C Hodges and I Sircar
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 963-969;

  19. Slater, C

    1. Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors.
      D E Semler, E H Ohlstein, P Nambi, C Slater and P H Stern
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1052-1058;

  20. Slemenda, C W

    1. Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.
      M Sato, J Kim, L L Short, C W Slemenda and H U Bryant
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1252-1259;

  21. Smith, J E

    1. Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats.
      T J Martin, S I Dworkin and J E Smith
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1135-1140;

  22. Smith, P L

    1. Nonpeptide endothelin receptor antagonists: IV. Identification of receptors in rabbit colonic mucosa and smooth muscle and correlation with physiological effects.
      P L Smith, C P Lee, M Pullen, E H Ohlstein, G Beck, E P Eddy and P Nambi
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1204-1210;

  23. Stacey, N H

    1. Mechanism of ketoconazole-induced elevation of individual serum bile acids in the rat: relationship to the effect of ketoconazole on bile acid uptake by isolated hepatocytes.
      S A Azer, V Kukongviriyapan and N H Stacey
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1231-1237;

  24. Stanisic, D S

    1. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
      A A Hancock, S A Buckner, W J Giardina, M E Brune, J Y Lee, P A Morse, K W Oheim, D S Stanisic, R B Warner and D J Kerkman
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1160-1169;

  25. Stein, P D

    1. BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.
      M L Webb, J E Bird, E C Liu, P M Rose, R Serafino, P D Stein and S Moreland
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1124-1134;

  26. Stern, P H

    1. Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors.
      D E Semler, E H Ohlstein, P Nambi, C Slater and P H Stern
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1052-1058;

  27. Stimpson, S A

    1. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
      M W Verghese, R T McConnell, A B Strickland, R C Gooding, S A Stimpson, D P Yarnall, J D Taylor and P J Furdon
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1313-1320;

  28. St Peter, J V

    1. Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.
      D E Keyler, D G Le Couteur, S M Pond, J V St Peter and P R Pentel
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1117-1123;

  29. Stresser, D M

    1. Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit.
      S E Shehin-Johnson, D E Williams, S Larsen-Su, D M Stresser and R N Hines
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1293-1299;

  30. Strickland, A B

    1. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
      M W Verghese, R T McConnell, A B Strickland, R C Gooding, S A Stimpson, D P Yarnall, J D Taylor and P J Furdon
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1313-1320;

T

  1. Takahashi, S

    1. Effects of cyclopiazonic acid on rat myocardium: inhibition of calcium uptake into sarcoplasmic reticulum.
      S Takahashi, Y Kato, M Adachi, N Agata, H Tanaka and K Shigenobu
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1095-1100;

  2. Takayanagi, S

    1. Serotonin uptake and its modulation in rat jejunal enterocyte preparation.
      S Takayanagi, H Hanai, J Kumagai and E Kaneko
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1151-1159;

  3. Takeuchi, M

    1. Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats.
      A Katoh, M Eigyo, C Ishibashi, Y Naitoh, M Takeuchi, N Ibii, M Ikeda and A Matsushita
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1067-1075;

  4. Tanaka, H

    1. Effects of cyclopiazonic acid on rat myocardium: inhibition of calcium uptake into sarcoplasmic reticulum.
      S Takahashi, Y Kato, M Adachi, N Agata, H Tanaka and K Shigenobu
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1095-1100;

  5. Tao, X

    1. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F.
      X Tao, J J Cai and P E Lipsky
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1305-1312;

  6. Taylor, J D

    1. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
      M W Verghese, R T McConnell, A B Strickland, R C Gooding, S A Stimpson, D P Yarnall, J D Taylor and P J Furdon
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1313-1320;

  7. Templeton, E

    1. Metabolism and bioactivation of clozapine by human liver in vitro.
      M Pirmohamed, D Williams, S Madden, E Templeton and B K Park
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 984-990;

  8. Thakore, E

    1. Ring and link requirements for tocainide binding to the class I antiarrhythmic drug receptor on rat cardiac myocytes.
      R S Sheldon and E Thakore
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1005-1010;

  9. Thornley, C

    1. Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.
      B A Bennett, C H Wichems, C K Hollingsworth, H M Davies, C Thornley, T Sexton and S R Childers
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1176-1186;

  10. Tochihara, M

    1. Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis.
      M Matsumoto, M Yoshioka, H Togashi, M Tochihara, T Ikeda and H Saito
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1044-1051;

  11. Togashi, H

    1. Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis.
      M Matsumoto, M Yoshioka, H Togashi, M Tochihara, T Ikeda and H Saito
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1044-1051;

  12. Tracey, W R

    1. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors.
      W R Tracey, J Tse and G Carter
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1011-1015;

  13. Tse, J

    1. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors.
      W R Tracey, J Tse and G Carter
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1011-1015;

V

  1. Valente, L

    1. Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism.
      J O Miners, D L Rees, L Valente, M E Veronese and D J Birkett
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1076-1081;

  2. Van Belle, K

    1. Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study.
      K Van Belle, S Sarre, G Ebinger and Y Michotte
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1217-1222;

  3. Van Huysse, J W

    1. In vivo renal production and tubular secretion of tyramine.
      J W Van Huysse, D P Henry and L R Willis
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1187-1192;

  4. Verghese, M W

    1. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
      M W Verghese, R T McConnell, A B Strickland, R C Gooding, S A Stimpson, D P Yarnall, J D Taylor and P J Furdon
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1313-1320;

  5. Veronese, M E

    1. Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism.
      J O Miners, D L Rees, L Valente, M E Veronese and D J Birkett
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1076-1081;

W

  1. Wahl, S M

    1. Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking.
      L R Flores, S M Wahl and B M Bayer
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1246-1251;

  2. Warner, R B

    1. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
      A A Hancock, S A Buckner, W J Giardina, M E Brune, J Y Lee, P A Morse, K W Oheim, D S Stanisic, R B Warner and D J Kerkman
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1160-1169;

  3. Warner, T E

    1. Nitric oxide synthase inhibitor and lipopolysaccharide effects on reactivity of guinea pig airways.
      J S Fedan, T E Warner, L X Yuan, V a Robinson and D G Frazer
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1141-1150;

  4. Webb, M L

    1. BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.
      M L Webb, J E Bird, E C Liu, P M Rose, R Serafino, P D Stein and S Moreland
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1124-1134;

  5. Westfall, D P

    1. Differences in purinoceptor modulation of norepinephrine release between caudal arteries of normotensive and hypertensive rats.
      K Shinozuka, M Kunitomo, K Hattori, R A Bjur and D P Westfall
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1193-1198;

  6. Wichems, C H

    1. Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.
      B A Bennett, C H Wichems, C K Hollingsworth, H M Davies, C Thornley, T Sexton and S R Childers
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1176-1186;

  7. Williams, D

    1. Metabolism and bioactivation of clozapine by human liver in vitro.
      M Pirmohamed, D Williams, S Madden, E Templeton and B K Park
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 984-990;

  8. Williams, D E

    1. Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit.
      S E Shehin-Johnson, D E Williams, S Larsen-Su, D M Stresser and R N Hines
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1293-1299;

  9. Williams, K

    1. Antagonist properties of polyamines and bis(ethyl)polyamines at N-methyl-D-aspartate receptors.
      K Igarashi and K Williams
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1101-1109;

  10. Willis, L R

    1. In vivo renal production and tubular secretion of tyramine.
      J W Van Huysse, D P Henry and L R Willis
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1187-1192;

  11. Wong, E H

    1. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine.
      D W Bonhaus, K R Bley, C A Broka, D J Fontana, E Leung, R Lewis, A Shieh and E H Wong
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1199-1203;

  12. Wood, R W

    1. Airway smooth muscle relaxant effects of the cocaine pyrolysis product, methylecgonidine.
      H A el-Fawal and R W Wood
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 991-996;

  13. Wuorela, H

    1. Arterial function after trichlormethiazide therapy in spontaneously hypertensive rats.
      M Kähönen, H Mäkynen, P Arvola, H Wuorela and I Pörsti
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1223-1230;

X

  1. Xue, J

    1. Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung.
      G Bannenberg, J Xue, L Engman, I Cotgreave, P Moldéus and A Ryrfeldt
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1238-1245;

Y

  1. Yarnall, D P

    1. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
      M W Verghese, R T McConnell, A B Strickland, R C Gooding, S A Stimpson, D P Yarnall, J D Taylor and P J Furdon
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1313-1320;

  2. Yoshioka, M

    1. Modulation of norepinephrine release by serotonergic receptors in the rat hippocampus as measured by in vivo microdialysis.
      M Matsumoto, M Yoshioka, H Togashi, M Tochihara, T Ikeda and H Saito
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1044-1051;

  3. Yuan, L X

    1. Nitric oxide synthase inhibitor and lipopolysaccharide effects on reactivity of guinea pig airways.
      J S Fedan, T E Warner, L X Yuan, V a Robinson and D G Frazer
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1141-1150;

Z

  1. Zhong, H

    1. Coexisting beta-1 and beta-2-adrenergic receptors with differential receptor reserves in rat C6 glioma cells.
      H Zhong and K P Minneman
      Journal of Pharmacology and Experimental Therapeutics March 1995, 272 (3) 1088-1094;
Back to top

In this issue